Inhibition of the RNA-Dependent Transactivation and Replication of Human Immunodeficiency Virus Type 1 by a Fluoroquinoline Derivative K-37
- 1 July 2000
- Vol. 272 (2), 402-408
- https://doi.org/10.1006/viro.2000.0396
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Multifaceted Activities of the HIV-1 Transactivator of Transcription, TatJournal of Biological Chemistry, 1999
- Taking a new TAK on Tat transactivationGenes & Development, 1997
- The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIGenes & Development, 1997
- Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivativesAntimicrobial Agents and Chemotherapy, 1997
- Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription.The EMBO Journal, 1997
- Synergistic Activation of Transcription by the Mutant and Wild-type Minimal Transcriptional Activation Domain of VP16Published by Elsevier ,1996
- Alternative mechanisms of CAK assembly require an assembly factor or an Activating KinaseCell, 1995
- Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase IIScience, 1995
- Inhibition of HIV Replication in Acute and Chronic Infections in Vitro by a Tat AntagonistScience, 1991
- Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivityNature, 1991